Clincosm LogoSign in Get a demo

alzheimer´s disease

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer´s Disease Trial in Worldwide (Immune Globulin Intravenous (Human), 10% Solution, Human albumin 0.25%)

Terminated
Has Results
  • Alzheimer´s Disease
  • Immune Globulin Intravenous (Human), 10% Solution
  • Human albumin 0.25%
  • Birmingham, Alabama
  • +68 more
Apr 30, 2021

Alzheimer´s Disease Trial in Rochester (Immune Globulin Intravenous (Human), 10% (IGIV, 10%))

Terminated
Has Results
  • Alzheimer´s Disease
  • Immune Globulin Intravenous (Human), 10% (IGIV, 10%)
  • Rochester, New York
    (unnamed)
Apr 30, 2021

Alzheimer´s Disease Trial in Canada, United States (Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 400 mg/kg, Immune

Completed
Has Results
  • Alzheimer´s Disease
  • Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 400 mg/kg
  • +3 more
  • Birmingham, Alabama
  • +40 more
Apr 30, 2021

Alzheimer´s Disease Trial in Worldwide (Lanabecestat, Placebo)

Terminated
Has Results
  • Alzheimer´s Disease
  • Phoenix, Arizona
  • +253 more
Nov 19, 2019

EEG-cholinergic Index and Clinical Response to Treatment With

Unknown status
  • Alzheimer´s Disease
    • (no location specified)
    Aug 16, 2018

    Retinal Neurodegeneration, Alzheimer´s Disease, Type 2 Diabetes Trial in Barcelona

    Completed
    • Retinal Neurodegeneration
    • +2 more
      • Barcelona, Catalunya, Spain
        Vall d´Hebron Research Institute VHIR
      Apr 11, 2017

      Alzheimer´s Disease, Diabetes Type 2 Trial in Barcelona (There is a retrospectiv observational study. No intervention)

      Completed
      • Alzheimer´s Disease
      • Diabetes Mellitus Type 2
      • There is a retrospectiv observational study. No intervention
      • Barcelona, Spain
        Vall d´Hebron University Hospital
      Apr 11, 2017

      Previous Exposure to General Anesthesia and Development of

      Unknown status
      • Alzheimer´s Disease
      • General Anesthesia
        • Linkoping, Sweden
          University Hospital
        Mar 24, 2016

        Alzheimer´s Disease Trial in Worldwide (AFFITOPE® AD02, Placebo)

        Terminated
        • Alzheimer´s Disease
        • AFFITOPE® AD02
        • Placebo
        • Hall in Tirol, Austria
        • +26 more
        Jun 23, 2015

        AFF002 and AFF004A in Patients With Alzheimer's Disease

        Terminated
        • Alzheimer´s Disease
          • Vienna, Austria
          • +1 more
          Dec 10, 2013

          Alzheimer´s Disease Trial (Lornoxicam, Placebo)

          Terminated
          Has Results
          • Alzheimer´s Disease
          • (no location specified)
          Feb 1, 2013

          Alzheimer´s Disease Trial in Russian Federation, Ukraine (AZD1446, Donepezil, Placebo)

          Terminated
          • Alzheimer´s Disease
          • Kazan, Russian Federation
          • +6 more
          May 11, 2011

          AD01 Follow up Extension Visit

          Completed
          • Alzheimer´s Disease
            • Wien, Austria
              Univ. Klinik für Neurologie
            Jan 25, 2011

            Alzheimer´s Disease Trial in Chemnitz, Leipzig, Nürnberg (NP031112, Placebo)

            Completed
            • Alzheimer´s Disease
            • Chemnitz, Germany
            • +2 more
            Nov 10, 2009

            Alzheimer´s Disease Trial in Stockholm (Radioligand (11C)AZD2995, Radioligand (11C)AZD2184)

            Completed
            • Alzheimer´s Disease
            • Radioligand (11C)AZD2995
            • Radioligand (11C)AZD2184
            • Stockholm, Sweden
              Research Site
            Jan 22, 2009

            Alzheimer´s Disease Trial (copper, )

            Completed
            • Alzheimer´s Disease
            • copper
            • placebo
            • (no location specified)
            Feb 5, 2008